4//SEC Filing
Lieu Hsiao D 4
Accession 0001209191-23-016392
CIK 0001426332other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 5:08 PM ET
Size
7.7 KB
Accession
0001209191-23-016392
Insider Transaction Report
Form 4
Lieu Hsiao
SVP, Chief Medical Officer
Transactions
- Award
Common Stock
2023-03-02+53,000→ 55,605 total - Award
Stock Option (Right to Buy)
2023-03-02+159,000→ 159,000 totalExercise: $4.36Exp: 2033-03-01→ Common Stock (159,000 underlying)
Footnotes (3)
- [F1]Represents shares of common stock issuable upon the vesting and settlement of restricted stock units ("RSUs"). 1/4th of the RSUs vest on each of January 15, 2024, January 15, 2025, January 15, 2026 and January 15, 2027.
- [F2]Includes 1,352 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on November 15, 2021, 1,252 ESPP shares acquired on May 13, 2022 and 1 ESPP share acquired on November 15, 2022.
- [F3]The shares subject to the stock option vest over a four-year period commencing January 1, 2023, with 1/48th of the shares vesting on a monthly basis.
Documents
Issuer
NGM BIOPHARMACEUTICALS INC
CIK 0001426332
Entity typeother
Related Parties
1- filerCIK 0001468482
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 5:08 PM ET
- Size
- 7.7 KB